These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35130553)

  • 1. Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A.
    Mere Del Aguila E; Tang XH; Gudas LJ
    Oncol Res Treat; 2022; 45(5):291-298. PubMed ID: 35130553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced retinoids and retinoid receptors' expression in pancreatic cancer: A link to patient survival.
    Bleul T; Rühl R; Bulashevska S; Karakhanova S; Werner J; Bazhin AV
    Mol Carcinog; 2015 Sep; 54(9):870-9. PubMed ID: 24729540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis.
    Hrabak P; Zelenkova M; Krechler T; Soupal J; Vocka M; Hanus T; Petruzelka L; Svacina S; Zak A; Zima T; Kalousova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Jun; 168(2):132-138. PubMed ID: 38058194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRABP2 and FABP5 expression levels in diseased and normal pancreas.
    Hughes CS; ChinAleong JA; Kocher HM
    Ann Diagn Pathol; 2020 Aug; 47():151557. PubMed ID: 32593808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines.
    Rosewicz S; Stier U; Brembeck F; Kaiser A; Papadimitriou CA; Berdel WE; Wiedenmann B; Riecken EO
    Gastroenterology; 1995 Nov; 109(5):1646-60. PubMed ID: 7557150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax.
    Pettersson F; Dalgleish AG; Bissonnette RP; Colston KW
    Br J Cancer; 2002 Aug; 87(5):555-61. PubMed ID: 12189556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid targets for the treatment of cancer.
    Buletic Z; Soprano KJ; Soprano DR
    Crit Rev Eukaryot Gene Expr; 2006; 16(3):193-210. PubMed ID: 17073551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
    Froeling FE; Feig C; Chelala C; Dobson R; Mein CE; Tuveson DA; Clevers H; Hart IR; Kocher HM
    Gastroenterology; 2011 Oct; 141(4):1486-97, 1497.e1-14. PubMed ID: 21704588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short report - Lethal and aggressive pancreatic cancer: molecular pathogenesis, cellular heterogeneity, and biomarkers of pancreatic ductal adenocarcinoma.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1017-1019. PubMed ID: 35179767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
    Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
    BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids in the pancreas.
    Brun PJ; Wongsiriroj N; Blaner WS
    Hepatobiliary Surg Nutr; 2016 Feb; 5(1):1-14. PubMed ID: 26904552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling pathway in pancreatic tumorigenesis.
    Chung WC; Xu K
    Adv Cancer Res; 2023; 159():1-36. PubMed ID: 37268393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse actions of retinoid receptors in cancer prevention and treatment.
    Mongan NP; Gudas LJ
    Differentiation; 2007 Nov; 75(9):853-70. PubMed ID: 17634071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.